Clinical Trials Logo

Vision, Low clinical trials

View clinical trials related to Vision, Low.

Filter by:

NCT ID: NCT03192722 Completed - Clinical trials for Ocular Conditions Resulting in Visual Impairment

Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2

Start date: April 20, 2017
Phase: N/A
Study type: Interventional

The effect of tinted filters and illumination on the visual performance of patients with low vision (i.e., individuals with reduced vision that is uncorrectable with glasses, surgery or treatments) has been a topic of research and discussion for many years, yet there is no current consensus or practice standard for the evaluation and recommendation of colored filters and/or illumination intensity. Anecdotally, there have been many subjective reports of improvement in visual function and comfort with the use of tinted lenses. Previous studies have attempted to elucidate the subjective improvements observed using vision tests, such as visual acuity and contrast sensitivity, and the findings have been inconsistent. Traditionally, filters and optimal illumination are prescribed clinically through a trial and error method, which involves trying various filters and lamps haphazardly to determine which if any are preferred by the patient. The investigators are proposing to evaluate whether the illumination and filters chosen in office by participants using a new assessment tool the LuxIQ/2 translate to overall patient comfort and improved speed, accuracy and print size while reading, and to evaluate whether participants have the same illumination and colored filter preference determined by the LuxIQ/2 in a clinical office setting and in their home environment. The investigators will evaluate whether participants prefer lighting determined by the new assessment tool the LuxIQ/2 in comparison to lighting determined by the OttLite Cobra in office.

NCT ID: NCT03141164 Completed - Cognitive Change Clinical Trials

Peripheral Vision Training Study

PVTS
Start date: May 30, 2017
Phase: N/A
Study type: Interventional

This study will train participants (young people and older adults) to do a visual task, and will assess whether this results in changes in behavioral assessments. In some participants, we will be also testing whether MRI measures (cortical thickness, functional connectivity) change with training.

NCT ID: NCT03065907 Completed - Clinical trials for Neovascular Age-related Macular Degeneration

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

TRAVIT
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The purpose of this research is to collect preliminary data in preparation for conducting a randomized clinical trial to determine the relative effectiveness of vision rehabilitation in improving overall visual ability (primary aim) and reducing depression (secondary aim) in patients receiving anti-VEGF therapy for neovascular age-related macular degeneration integrated over time.

NCT ID: NCT03028493 Completed - Fall Clinical Trials

Increasing the Accessibility of a Falls Prevention Intervention for Community Dwelling Older Adults With Low Vision

Start date: January 18, 2017
Phase: N/A
Study type: Interventional

This study serves to test a previously evaluated falls prevention intervention recommended by the Centers for Disease Control and Prevention, entitled the Study of Accidental Falls in the Elderly (SAFE) Health Behavior and Exercise Intervention, to evaluate if the intervention is accessible to older adults with low vision receiving services from the Southeastern Blind Rehabilitation Center (SBRC). This study also serves to pilot a version of the SAFE intervention that has been adapted to be accessible for individuals with low vision at SBRC.

NCT ID: NCT02983305 Completed - Healthy Clinical Trials

Optical Head-Mounted Display Technology for Low Vision Rehabilitation

Start date: June 26, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to examine the ability of optical head‐mounted display technology to enlarge the visual field of patients with severe visual field loss due to retinal dystrophy and to improve mobility and patient‐reported outcomes.

NCT ID: NCT02896738 Completed - Visual Impairment Clinical Trials

MRI Screening for Auditory Pathway Malformations in Visually Impaired Children

DIMAVE
Start date: September 2015
Phase:
Study type: Observational

This pilot study aims to assess the interest to add an auditory pathway morphological analysis during the MRI exploration of visual pathway in visually impaired children.

NCT ID: NCT02616900 Completed - Vision, Low Clinical Trials

eSight Eyewear Quality of Life and Efficacy Study

eQUEST
Start date: December 16, 2015
Phase: N/A
Study type: Interventional

The "eSight Quality of Life and Efficacy Study" (eQUEST) is a prospective cohort study intended to demonstrate the functional vision and Quality of Life (QoL) improvement provided by eSight Eyewear to persons with significant visual impairment resulting from various eye conditions. The multi-site study will evaluate the efficacy of the eSight device for various Activities of Daily Living (ADLs) across a broad range of subject ages and disease types.

NCT ID: NCT02607384 Completed - Refractive Error Clinical Trials

The Baltimore Reading and Eye Disease Study

BREDS
Start date: November 2014
Phase: N/A
Study type: Interventional

The Baltimore Reading and Eye Disease Study (BREDS) is a two year study to determine the prevalence of vision problems in an early school age population with reading difficulty. Comprehensive vision and reading tests will be administered to 400 students at participating schools in the Baltimore City Public School system. A secondary goal is to examine the impact of vision treatment on reading performance. Children with refractive error or convergence insufficiency will be provided treatment free of charge. The investigators will evaluate the impact that the treatment has on vision function and reading performance.

NCT ID: NCT02480452 Completed - Clinical trials for Visual Pathway Diseases; Neuroimaging

Brain Lesions in Relation to Motor Profiles of Children With Cerebral Visual Impairment.

Start date: May 2015
Phase:
Study type: Observational

The overall goal of this research proposal is the early prediction of the emergence of CVI and its characteristics on the basis of neuroimaging data. The different steps that will be taken to achieve this goal will be: 1. To characterize CVI deficits in children; 2. To correlate the CVI characteristics with their motor profiles; 3. To characterize brain lesions in children with CVI; 4. To link the motor profile, CVI profile and brain metrics of the children. Over the last 10 years, 488 children with and without CP have consulted at the CVI clinic in Leuven. All these children had a comprehensive visual perceptual assessment, cognitive evaluation and an ophthalmological assessment. Summarizing these data results in a quantitative visual perceptual profile for each individual patient. The goal is to prospectively extend this database to a number of 600 children. The project's primary objective is to relate the presence of CVI to the motor profiles of these children. Of these 488 children, 300 have an MRI available. The goal is to analyze the retrospective MRI data of this clinical group and to prospectively extend this database by reassuring newly registered children will receive MRI with DTI. This will allow the investigation of the correlation between the brain metrics and the CVI characteristics in a large cohort.

NCT ID: NCT02310880 Completed - Low Vision Clinical Trials

Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World

Start date: September 2010
Phase: N/A
Study type: Observational

Low vision patients have difficulty acquiring sufficient visual information in a timely manner for the purpose of performing challenging daily tasks, such as traveling independently and safely through busy streets. The advance of virtual reality techniques has provided a potential platform for training low vision patients to use their remaining vision more efficiently, but the key issue is always whether the patient's visual experiences in a virtual world can be transferred to the real world. The proposed study is designed to provide definite answer to this question.